Cheong E Von Ho Gwo Fuang
10.1016/j.rmcr.2021.101478
Respir Med Case Rep
2021 Jul 13;34:101478.
alk alk, anaplastic lymphoma kinase adenocarcinoma atezolizumab ici, immune checkpoint inhibitor immune checkpoint inhibitor lung cancer nsclc, non-small cell lung cancer non-small cell pd-1, programmed death-1 pdl-1, programmed death ligand-1 tki, tyrosine kinase inhibitor
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34336591/
Case Reports
PMC8318922
34336591
A case of remarkable response to atezolizumab in ALK-translocated metastatic lung adenocarcinoma
2021